2023-11-11 13:05:00
This initiative follows a alarming 50% increase in cases over the past yearreaching a historic peak with 82,592 people diagnosed in 2022, the highest figure since records began in 1918. The Joint Committee on Vaccination and Immunization (JCVI) has issued a crucial recommendation to the government, suggesting the implementation of a vaccination program aimed at reducing the risk of contracting gonorrhea. The planned vaccine, and MenB, already used to protect once morest meningitis and septicemia, demonstrated an estimated effectiveness between 32.7% and 42% in studies.
The JCVI offers a targeted approach, by prioritizing gay men through sexual health services for this vaccination program. This preventive measure might also iinclude vaccination once morest mpox, formerly known as monkeypox (monkey pox), for this high-risk group.
“The introduction of a MenB vaccination program to prevent gonorrhea in England would be a world first and is expected to make a significant contribution to reducing gonorrhea rates, which are currently at an all-time high,” says Professor Andrew Pollard, President of the JCVI.
Beyond the fight once morest gonorrhea, the JCVI also recommends a systematic and targeted vaccination program once morest smallpox, in response to the large-scale epidemic observed at the beginning of 2022. This dual approach aims to protect those most at risk of infection, with operational details to be defined following ministerial approval. Katy Sinka, head of sexually transmitted infections at the UK Health Security Agency, welcomed the proposal as a hugely welcome intervention. She emphasized that, Faced with the growing resistance of gonorrhea to antibiotics, a systematic vaccination initiative might strengthen preparedness to face this constantly evolving threat (source 1).
However, as attention focuses on gonorrhea, experts stress the need to not to neglect smallpox, emphasizing that although cases are currently rare in England, continued vigilance is essential to prevent possible major outbreaks in the future. Any systematic vaccination program targeting those most at risk of infection will, they believe, help maintain control of these diseases and to avoid devastating epidemic situations. The final decision on these new vaccination programs now rests in the hands of ministers at the Department of Health and Social Affairs. If the advice is accepted, operational details on vaccine rollout will be developed to deliver this major breakthrough in UK public health.
1699763050
#England #set #country #distribute #STI #vaccine
